These results highlight the tumor-induced plasticity of the alveolar capillary endothelium and reveal PIM3 as a regulator of EC barrier integrity, which may explain the lack of efficacy of PIM inhibition so far in clinical cancer trials17,18. This evidence concerns the gene PIM3 and cancer.